Literature DB >> 30726535

EEG Abnormalities as a Neurophysiological Biomarker of Severity in Autism Spectrum Disorder: A Pilot Cohort Study.

Antonio Gennaro Nicotera1, Randi Jenssen Hagerman2, Maria Vincenza Catania3,4, Serafino Buono5, Santo Di Nuovo6, Elisa Maria Liprino7, Emanuela Stracuzzi7, Stefania Giusto7, Giuseppina Di Vita7, Sebastiano Antonino Musumeci7.   

Abstract

To date, the phenotypic significance of EEG abnormalities in patients with ASD is unclear. In a population affected by ASD we aimed to evaluate: the phenotypic characteristics; the prevalence of EEG abnormalities; the potential correlations between EEG abnormalities and behavioral and cognitive variables. Sixty-nine patients with ASD underwent cognitive or developmental testing, language assessment, and adaptive behavior skills evaluation as well as sleep/wake EEG recording. EEG abnormalities were found in 39.13% of patients. EEG abnormalities correlated with autism severity, hyperactivity, anger outbursts, aggression, negative or destructive behavior, motor stereotypies, intellectual disability, language impairment and self-harm. Our findings confirmed that EEG abnormalities are present in the ASD population and correlate with several associated phenotypic features.

Entities:  

Keywords:  Autism spectrum disorder; Biomarker; Epileptiform abnormalities; Hyperactivity; Phenotype

Mesh:

Substances:

Year:  2019        PMID: 30726535     DOI: 10.1007/s10803-019-03908-2

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  8 in total

1.  Relationship between epileptiform discharges and social reciprocity or cognitive function in children with and without autism spectrum disorders: An MEG study.

Authors:  Tetsu Hirosawa; Paul F Sowman; Mina Fukai; Masafumi Kameya; Daiki Soma; Shoryoku Hino; Tatsuru Kitamura; Kyung-Min An; Yuko Yoshimura; Chiaki Hasegawa; Daisuke Saito; Takashi Ikeda; Mitsuru Kikuchi
Journal:  Psychiatry Clin Neurosci       Date:  2020-07-19       Impact factor: 5.188

Review 2.  Electroencephalographic Abnormalities in Autism Spectrum Disorder: Characteristics and Therapeutic Implications.

Authors:  Francesco Precenzano; Lucia Parisi; Valentina Lanzara; Luigi Vetri; Francesca Felicia Operto; Grazia Maria Giovanna Pastorino; Maria Ruberto; Giovanni Messina; Maria Cristina Risoleo; Claudia Santoro; Ilaria Bitetti; Rosa Marotta
Journal:  Medicina (Kaunas)       Date:  2020-08-19       Impact factor: 2.430

Review 3.  Inhibiting Epileptiform Activity in Cognitive Disorders: Possibilities for a Novel Therapeutic Approach.

Authors:  Andras Attila Horvath; Emoke Anna Csernus; Sara Lality; Rafal M Kaminski; Anita Kamondi
Journal:  Front Neurosci       Date:  2020-10-15       Impact factor: 4.677

4.  The Autism Palette: Combinations of Impairments Explain the Heterogeneity in ASD.

Authors:  Ábel Fóthi; Latha Soorya; András Lőrincz
Journal:  Front Psychiatry       Date:  2020-12-02       Impact factor: 4.157

Review 5.  EEG as a translational biomarker and outcome measure in fragile X syndrome.

Authors:  Aisling Kenny; Damien Wright; Andrew C Stanfield
Journal:  Transl Psychiatry       Date:  2022-01-24       Impact factor: 6.222

6.  Epileptiform discharges relate to altered functional brain networks in autism spectrum disorders.

Authors:  Tetsu Hirosawa; Kyung-Min An; Daiki Soma; Yuka Shiota; Masuhiko Sano; Masafumi Kameya; Shoryoku Hino; Nobushige Naito; Sanae Tanaka; Ken Yaoi; Sumie Iwasaki; Yuko Yoshimura; Mitsuru Kikuchi
Journal:  Brain Commun       Date:  2021-08-19

7.  Effect of anti-attention-deficit hyperactivity disorder (ADHD) medication on clinical seizures and sleep EEG: A retrospective study of Japanese children with ADHD.

Authors:  Hisako Yamamoto; Eiji Nakagawa; Yousuke Kita; Yoshimi Kaga; Masumi Inagaki
Journal:  Neuropsychopharmacol Rep       Date:  2021-10-20

8.  Epilepsy and electroencephalographic abnormalities in patients with diagnosis of idiopathic autism spectrum disorder in Medellín.

Authors:  Angélica Arteaga; Elizabeth Vélez; William Cornejo; Rodrigo Solarte; Angélica Lobo; Verónica Jaramillo; Julissa Otero
Journal:  Int J Psychol Res (Medellin)       Date:  2021 Jan-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.